Chengdu huasun technology group Inc. , LTD. (SHE:000790)
3.760
+0.060 (1.62%)
Oct 23, 2026, 3:04 PM CST
SHE:000790 Revenue
Chengdu huasun technology group Inc. , LTD. had revenue of 123.61M CNY in the quarter ending June 30, 2026, a decrease of -24.98%. This brings the company's total for the last twelve months to 486.70M, down -30.25% year-over-year. In the year 2025, Chengdu huasun technology group Inc. , LTD. had annual revenue of 545.50M, down -36.86%. That makes Chengdu huasun technology group Inc. , LTD. the 25,079th largest company in the world by revenue and 4,471st in China.
Revenue (ttm)
486.70M
Revenue Growth
-30.25%
P/S Ratio
4.82
Revenue / Employee
669.47K
Employees
727
Market Cap
2.35B
Revenue by Segment
- Pharmaceutical business 453.29M 62.0%
- Pharmaceutical Trading Division 125.85M 17.2%
- Healthy Drinks 124.82M 17.1%
- Steel Structure Manufacture 27.32M 3.7%
- New Materials and Chemicals Division 63.19K 0.0%
Fiscal year ended Dec 31, 2025 See the full SHE:000790 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 545.50M | -318.48M | -36.86% |
| Dec 31, 2024 | 863.98M | -139.40M | -13.89% |
| Dec 31, 2023 | 1.00B | 130.27M | 14.92% |
| Jan 1, 2023 | 873.10M | -81.58M | -8.55% |
| Jan 1, 2022 | 954.69M | 195.38M | 25.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Anhui Fengyuan Pharmaceutical | 3.50B |
| Guizhou Yibai Pharmaceutical | 1.56B |
| ShanXi C&Y Pharmaceutical Group Co.,LTD. | 849.67M |
| Zhejiang Shengda Bio-Pharm | 832.86M |
| Enwei Pharmaceutical | 826.13M |
| Chongqing Jiheng Pharmaceutical | 654.22M |
| Hainan Huluwa Pharmaceutical Group | 634.04M |
| Zhejiang Shapuaisi Pharmaceutical | 423.20M |